BIO: FDA draft report on biotech salmon is a step forward

An FDA draft evaluation on the safety of AquaBounty Technology's transgenic salmon is a good sign, said David Edwards, BIO's director of animal biotechnology. "It certainly looks good for the fish moving forward," Edwards said. "It shows that the Obama administration is willing to move forward on these technologies and allow the United States to be the leader that we should be."

View Full Article in:

United Press International · Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC